Further considerations in regards to commissioning of spine stereotactic ablative body radiotherapy
Affiliation
Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.Issue Date
2022
Metadata
Show full item recordCitation
Barker CL, King J, Colaco R. Further Considerations in Regards to Commissioning of Spine Stereotactic Ablative Body Radiotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)). 2022 Nov 3. PubMed PMID: 36336578. Epub 2022/11/07. eng.Journal
Clinical OncologyDOI
10.1016/j.clon.2022.10.007PubMed ID
36336578Additional Links
https://dx.doi.org/10.1016/j.clon.2022.10.007Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2022.10.007
Scopus Count
Collections
Related articles
- Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
- Authors: Abbas G, Danish A, Krasna MJ
- Issue date: 2016 Jul
- Non-surgical treatment of lung cancer: personalised stereotactic ablative radiotherapy.
- Authors: Tsang MW, Kam MK, Leung SF, Chan AT
- Issue date: 2014 Dec
- Stereotactic ablative radiation therapy for primary lung tumors.
- Authors: Heinzerling JH, Kavanagh B, Timmerman RD
- Issue date: 2011 Jan-Feb
- A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
- Authors: Timmerman RD, Fernando HC
- Issue date: 2013 Spring
- [Stereotactic ablative irradiation for lung cancer].
- Authors: Antoni D, Srour I, Noël G, Mornex F
- Issue date: 2014 Jul-Aug